Synthesis, <i>in silico</i> study and cytotoxic evaluation of new benzimidazole derivatives as potential aromatase inhibitors


Isik A., Daoud N. E., Ciftci K. U., Çongur G., Ay E. N., Bagci E. R., ...Daha Fazla

FUTURE MEDICINAL CHEMISTRY, 2026 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1080/17568919.2026.2748643
  • Dergi Adı: FUTURE MEDICINAL CHEMISTRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Chemical Abstracts Core, EMBASE, MEDLINE, Natural Science Collection (ProQuest), Biological Science Database (ProQuest), Health Research Premium Collection (ProQuest)
  • Anadolu Üniversitesi Adresli: Evet

Özet

Aims A new series of benzimidazole derivatives (4a-4p) was designed, synthesized, and evaluated as potential aromatase inhibitors with anticancer activity.Materials and methods The anticancer effects of the compounds were evaluated using the MCF-7 cell line. Derivatives that showed activity were subjected to an aromatase inhibition assay. Molecular docking, molecular dynamics simulations, and in silico ADMET profiling were performed for the selected compounds.Results Among the series, para-substituted derivatives 4d (Cl), 4h (OC2H5), and 4k (F) exhibited potent antiproliferative activity with low-micromolar IC50 values (2.40-2.64 & micro;M), surpassing cisplatin, while maintaining favorable selectivity profiles.Conclusions This experimental and computational study identifies 4d as a promising lead for further development as a non-steroidal aromatase inhibitor for breast cancer therapy.